World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
86
Citations
27582
World Ranking
1263
National Ranking
660

Overview

David W. Vaughn is affiliated with the Bill & Melinda Gates Foundation in the United States. Their research primarily focuses on medicine, with a concentration on infectious diseases and public health. The scientist's work encompasses multiple intersecting subfields including Epidemiology, Immunology, and Environmental and Occupational Health.

Their research covers several significant topics, among which are:

  • SARS-CoV-2 and COVID-19 Research
  • Mosquito-borne diseases and control
  • Malaria Research and Control
  • Respiratory viral infections research
  • Vaccine Coverage and Hesitancy
  • Viral gastroenteritis research and epidemiology
  • Viral Infections and Vectors

David W. Vaughn has authored and contributed to various scientific papers. Notable recent publications include:

  • Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization, 2021, Vaccine
  • Scientific rationale for developing potent RBD-based vaccines targeting COVID-19, 2021, npj Vaccines
  • Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities-workshop report, 2023, npj Vaccines
  • Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaques, 2020, PLoS Neglected Tropical Diseases
  • Safety and Immunogenicity of an AS03B-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study, 2020, American Journal of Tropical Medicine and Hygiene

The scientist frequently publishes in a set of key venues, including:

  • American Journal of Tropical Medicine and Hygiene
  • npj Vaccines
  • Vaccine
  • PLoS Neglected Tropical Diseases
  • The Lancet Global Health

Throughout their work, David W. Vaughn collaborates with several coauthors, notably:

  • Stephen J. Thomas
  • Richard G. Jarman
  • Peter G. Smith
  • Padmini Srikantiah
  • Heather Friberg

Best Publications

  • Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity

    David W. Vaughn;Sharone Green;Siripen Kalayanarooj;Bruce L. Innis

  • High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever

    Daniel H. Libraty;Paul R. Young;Darren Pickering;Timothy P. Endy

  • Early Clinical and Laboratory Indicators of Acute Dengue Illness

    S. Kalayanarooj;D. W. Vaughn;S. Nimmannitya;S. Green

  • Dengue Virus Structural Differences That Correlate with Pathogenesis

    Katrin C. Leitmeyer;David W. Vaughn;Douglas M. Watts;Rosalba Salas

  • Neurological manifestations of dengue infection.

    Tom Solomon;Nguyen Minh Dung;David W Vaughn;Rachel Kneen;Rachel Kneen

  • Safety and Efficacy of a Recombinant Hepatitis E Vaccine

    Mrigendra Prasad Shrestha;Robert McNair Scott;Durga Man Joshi;Mammen P. Mammen

  • Differing Influences of Virus Burden and Immune Activation on Disease Severity in Secondary Dengue-3 Virus Infections

    Daniel H. Libraty;Timothy P. Endy;Huo-Shu H. Houng;Sharone Green

  • Epidemiology of Inapparent and Symptomatic Acute Dengue Virus Infection: A Prospective Study of Primary School Children in Kamphaeng Phet, Thailand

    Timothy P. Endy;Supamit Chunsuttiwat;Ananda Nisalak;Daniel H. Libraty

  • Dengue in the early febrile phase : Viremia and antibody responses

    David W. Vaughn;Sharone Green;Siripen Kalayanarooj;Bruce L. Innis

  • SEROTYPE-SPECIFIC DENGUE VIRUS CIRCULATION AND DENGUE DISEASE IN BANGKOK, THAILAND FROM 1973 TO 1999

    Ananda Nisalak;Timothy P. Endy;Suchitra Nimmannitya;Siripen Kalayanarooj

  • Early Immune Activation in Acute Dengue Illness Is Related to Development of Plasma Leakage and Disease Severity

    Sharone Green;David W. Vaughn;Siripen Kalayanarooj;Suchitra Nimmannitya

  • Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

    Anna P. Durbin;Ruth A. Karron;Wellington Sun;David W. Vaughn

  • Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion

    Nathalie Garçon;David W Vaughn;Arnaud M Didierlaurent

  • Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand.

    Timothy P. Endy;Ananda Nisalak;Supamit Chunsuttitwat;David W. Vaughn

  • Poliomyelitis-like illness due to Japanese encephalitis virus.

    Tom Solomon;Rachel Kneen;Nguyen Minh Dung;Vo Cong Khanh

  • Dengue Hemorrhagic Fever in Infants: Research Opportunities Ignored

    Scott B. Halstead;Nguyen Trong Lan;Thein Thein Myint;Than Nu Shwe

  • Analysis of Repeat Hospital Admissions for Dengue to Estimate the Frequency of Third or Fourth Dengue Infections Resulting in Admissions and Dengue Hemorrhagic Fever, and Serotype Sequences

    Robert V. Gibbons;Siripen Kalanarooj;Richard G. Jarman;Ananda Nisalak

  • Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

    N. Kanesa-thasan;W. Sun;G. Kim-Ahn;S. Van Albert

  • HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais

    H. A. F. Stephens;H. A. F. Stephens;R. Klaythong;M. Sirikong;D. W. Vaughn

  • Etiology of interepidemic periods of mosquito-borne disease

    S I Hay;M F Myers;D S Burke;D W Vaughn

  • Impact of Dengue Virus Infection on Feeding Behavior of Aedes aegypti

    Kenneth B. Platt;Kenneth J. Linthicum;Khin S. A. Myint;Bruce L. Innis

  • Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever.

    Sharone Green;Sathit Pichyangkul;David W. Vaughn;Siripen Kalayanarooj

  • Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis

    Tom Solomon;Nguyen Minh Dung;Rachel Kneen;Le Thi Thu Thao

  • Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performance.

    Stephen J. Thomas;Ananda Nisalak;Kathryn B. Anderson;Daniel H. Libraty

  • Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study.

    Katie B Anderson;Supamit Chunsuttiwat;Ananda Nisalak;Mammen P Mammen

  • Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial

    Tom Solomon;Tom Solomon;Nguyen Minh Dung;Bridget Wills;Rachel Kneen

  • Viremia, Fecal Shedding, and IgM and IgG Responses in Patients with Hepatitis E

    Edward T. Clayson;Khin Saw Aye Myint;Rapin Snitbhan;David W. Vaughn

  • Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine.

    Robert Edelman;Steven S. Wasserman;Sacared A. Bodison;Robert J. Putnak

  • Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period.

    V. Wittke;T.E. Robb;H.M. Thu;A. Nisalak

  • Pathogenesis and Clinical Features of Japanese Encephalitis and West Nile Virus Infections

    T. Solomon;D. W. Vaughn

Frequent Co-Authors

Bruce L. Innis
Bruce L. Innis GlaxoSmithKline (United Kingdom)
Ananda Nisalak
Ananda Nisalak United States Department of the Army
Sharone Green
Sharone Green University of Massachusetts Chan Medical School
Francis A. Ennis
Francis A. Ennis University of Massachusetts Chan Medical School
Alan L. Rothman
Alan L. Rothman University of Rhode Island
Timothy P. Endy
Timothy P. Endy SUNY Upstate Medical University
Charles H. Hoke
Charles H. Hoke Walter Reed Army Institute of Research
Kenneth H. Eckels
Kenneth H. Eckels Walter Reed Army Institute of Research
Daniel H. Libraty
Daniel H. Libraty University of Massachusetts Chan Medical School
Ichiro Kurane
Ichiro Kurane National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Immunology in the USA often goes hand-in-hand with expanding knowledge in healthcare fields like nursing. For those interested in advanced clinical roles, understanding the doctor of nursing practice salary can provide insight into the financial benefits of higher education and specialized training.

Many nurses seek to advance their expertise through focused programs such as the fnp to acute care np bridge program, which helps Family Nurse Practitioners transition to more specialized acute care roles. This pathway is ideal for those aiming to work in critical care settings, closely complementing immunology knowledge.

For students pursuing expedited education, the market offers excellent options like the accelerated nurse practitioner program. These programs allow faster progression to licensure and specialized practice, perfect for professionals eager to enhance their clinical skills efficiently.

Additionally, individuals without a nursing background can access foundational education through the best online rn programs for non nurses. These programs open the door to nursing careers, providing a solid base in healthcare that complements immunology studies and future clinical roles.

Best Scientists Citing David W. Vaughn

Trending Scientists

Recently Published Articles